Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 4/20 | 0.57 |
| ▸ | NPC1 | O15118 | 3/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.57 |
| ▸ | RECQL | P46063 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 3/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | SOAT2 | O75908 | 1/20 | 0.46 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.46 |
| ▸ | BCHE | P06276 | 2/20 | 0.44 |
| ▸ | ACHE | P22303 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | MGLL | Q99685 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1150793 | 1.00 | RAB9A (0.57) | RAB9ANPC1SMN1; SMN2RECQLTSHR | |
| SCHEMBL10817231 | 0.85 | RAB9A (0.75) | RAB9ANPC1SMN1; SMN2RECQLTSHR | |
| SCHEMBL17263428 | 0.85 | RAB9A (0.75) | RAB9ANPC1SMN1; SMN2RECQLTSHR | |
| SCHEMBL1150814 | 0.84 | RAB9A (0.61) | RAB9ANPC1SMN1; SMN2RECQLTSHR | |
| SCHEMBL6506711 | 0.84 | RAB9A (0.61) | RAB9ANPC1SMN1; SMN2RECQLTSHR | |
| SCHEMBL9712853 | 0.81 | RAB9A (0.57) | RAB9ANPC1SMN1; SMN2RECQLTSHR | |
| SCHEMBL10597471 | 0.80 | RAB9A (0.77) | RAB9ANPC1SMN1; SMN2RECQLTSHR | |
| SCHEMBL11325853 | 0.80 | RAB9A (0.63) | RAB9ANPC1SMN1; SMN2RECQLTSHR | |
| SCHEMBL10360236 | 0.78 | PSMB11 (0.55) | RAB9ANPC1SMN1; SMN2RECQLTSHR | |
| SCHEMBL1150745 | 0.78 | TDP1 (0.67) | RAB9ANPC1SMN1; SMN2TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110028746-A1 | METHOD FOR THE DECARBOXYLATIVE HYDROFORMYLATION OF ALPHA, BETA- UNSATURATED CARBOXYLIC ACIDS | BASF SE (DE) | 2011-02-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110028746-A1 | METHOD FOR THE DECARBOXYLATIVE HYDROFORMYLATION OF ALPHA, BETA- UNSATURATED CARBOXYLIC ACIDS | PCCA, CBR3, CBR1 | RAB9A 3747/4885NPC1 3310/4885SMN1; SMN2 1721/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.